MOv18 IgE Clinical Trials

1 actively recruiting trial

No change since May 2026

Pipeline

Phase 1: 1

Top Sponsors

Epsilogen Ltd1

Indications

Advanced Endometrial Cancer1
Advanced Ovarian Cancer1
Platinum-resistant Ovarian Cancer1
Triple Negative Breast Cancer (TNBC)1
Triple Negative Breast Cancer1

Other1 trial

A Study of MOv18 IgE in Patients With Solid Tumours That Express Folate Receptor Alpha

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.